Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
Pushing Past a Numerical Value With Advances in Glaucoma Research and Care
View Issue
Supported by Allergan Global Medical Affairs
View Insert
Supported by Quantel Medical
In This Issue
Arsham Sheybani, MD
Researchers studied postoperative phenomena and outcomes.
James C. Tsai, MD, MBA; Kateki Vinod, MD; and Rachel Lee, MD
What caused the IOP to rise dramatically 2 years after glaucoma surgery?
Douglas J. Rhee, MD | Section Editor; Thomas Patrianakos, MD; and Angela Turalba, MD
Waxing nostalgic while welcoming new tech to glaucoma.
Vincent P. Moscato, MD, and Albert S. Khouri, MD | Section Editor
A review of the pros and cons of premium IOLs in glaucomatous eyes.
Susan Liang, MD, and Sarwat Salim, MD, FACS | Section Editor
A closer look at the challenges of achieving health equity around the world.
Zaiba Malik, MD
Researchers studied motor vehicle accidents among patients with glaucoma.
Sheryl S. Wizov, COA; Eric J. Shiuey, MS; and Jonathan S. Myers, MD
IOP is just one piece of a complex puzzle.
Peter T. Chang, MD; Kevin L. Shen, MD; and Ronak S. Patel, MD
New drug targets and approaches to designing clinical trials hold promise for the development of neuroprotective therapies for glaucoma.
Wendy W. Liu, MD, PhD, and Milica A. Margeta, MD, PhD
Out with the old paradigm and in with the new.
Jeffrey L. Goldberg, MD, PhD
Optic nerve regeneration is becoming a reality.
Yuqin Yin, MD, PhD, and Larry I. Benowitz, PhD
Is a curative or preventive therapy on the horizon?
Janey L. Wiggs, MD, PhD
Pointers for shortening the learning curve and improving image quality.
Gagan Kalra, and Parul Ichhpujani, MS
Two ophthalmologists from different generations weigh in on finding happiness and balance in their careers.
Thomas A. Oetting, MD, and Ashley Brissette, MD, MSc, FRCSC
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.
